title: The effectiveness of bone density measurement and associated treatments for prevention of fractures. An international collaborative review.
abstract: This review assesses the evidence regarding the effectiveness of bone density measurement (BDM) screening and related interventions--hormone replacement therapy (HRT) and intranasal salmon calcitonin (SCT[N])--in menopausal women to prevent fractures in later life. Data sources included systematic reviews of evidence and relevant primary studies identified through literature searches on MEDLINE and EMBASE. Study selection included trials of BDM screening programs, prospective studies examining the predictive value of BDM, randomized controlled trials, cohort studies, and case-control studies of HRT and SCT (N). The evidence was evaluated using a classification system incorporating study design and quality. Outcomes were measured in terms of relative risk of fracture for a 1 SD decrease in bone mineral density below the age-adjusted mean, relative risks or odds ratios for fractures associated with treatments, and proportion of hip fractures potentially prevented by BDM screening linked to treatments. Fair evidence from prospective cohort studies suggests that BDM can predict the risk of fractures, but not with high accuracy. Fair evidence from low-quality randomized controlled trials and observational studies suggests that HRT and SCT(N) are efficacious in preventing fractures. Good evidence supports the efficacy of these treatments in preserving bone mass, but there is fair evidence that the effect wears off after cessation of therapy. There is little evidence on the impact of screening menopausal women with BDM in association with HRT or SCT(N) treatment. Estimates based on combining existing evidence regarding the predictive value of BDM and efficacy of HRT suggests that 1-7% of hip fractures might be prevented.
authors.affiliation: Alberta Heritage Foundation for Medical Research.
authors.forename: D
authors.initials: D
authors.lastname: Hailey
authors.forename: L
authors.initials: L
authors.lastname: Sampietro-Colom
authors.forename: D
authors.initials: D
authors.lastname: Marshall
authors.forename: R
authors.initials: R
authors.lastname: Rico
authors.forename: A
authors.initials: A
authors.lastname: Granados
authors.forename: J
authors.initials: J
authors.lastname: Asua
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D015519:Bone Density / Q000502:physiology*; D002116:Calcitonin / Q000008:administration & dosage; D003720:Densitometry; D015914:Estrogen Replacement Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000517:prevention & control; D011237:Predictive Value of Tests; D013673:Technology Assessment, Biomedical
chemical_list: D002116:Calcitonin